nach oben

vorheriger Artikel Prognostic factors and their correlation with s...

nächster Artikel Notes on breast cancer prevention and screening

Tipp

A 59-year-old patient with somatic type malignancy as a relapse of testicular tumor after 28 years

A patient with somatic type malignancy

Zeitschrift:: memo - Magazine of European Medical Oncology > Ausgabe 3/2015

Autoren:: MD Andreas Edwin Juarso, MD Malte Kiehl, MD Olaf Pfennig, MD Günther Wittenberg, MD Florian Weissinger

» Jetzt Zugang zum Volltext erhalten

Abstract

A 59-year-old patient presented in the outpatient clinic because of an increasing mass in his right buttock. He has a history of a testicular tumor 28 years ago, with increased tumor markers (Human Choriongonadotropin (β-HCG) value 4.9 and Alpha-1 Fetoprotein (AFP) 218 ng/ml).

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Jetzt einloggen Kostenlos registrieren

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

Abo für kostenpflichtige Inhalte

Jetzt informieren

Collins DH, Pugh RC. Classification and frequency of testicular tumours. Br J Urol. 1964;36:1–11. CrossRefPubMed

Winter E, Kliesch S, Souchon R, de Maike W. Diagnosis of testicular cancer. Dtsch Arztebl. 2005;102:A 3021–5 (Heft 44).

Ulbright TM. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol. 2005;18 Suppl 2:S61–79. CrossRefPubMed

Stamatiou K, Papadopoulos P, Perlepes G, Galariotis N, Olympitis M, Moschouris H, Vasilakaki T. Mixed germ tumor of the testicle with ravdomuosarcomatous component: a case report. Cases J. 2009;2:9299. PubMedCentralCrossRefPubMed

Krege S, et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part I. Eur Urol. 2008;53(3):478–96. CrossRefPubMed

Hanna NH, Einhorn LH. Testicular cancer—discoveries and updates. N Engl J Med. 2014;371:2005–16. CrossRefPubMed

Krege S, Albers P, Schmidberger H. Treatment of non-metastatic and moderate metastatic testicular cancer. Dtsch Arztebl. 2005;102:A 3191–4 (Heft 46).

Bokemeyer C, Beyer J, Heidenreich A. Treatment of patients with metastatic germ cell tumors. Dtsch Arztebl. 2005;102:A 3271–5 (Heft 47).

Pottek TS, Hartmann M, Bokemeyer C. Aftercare and delayed toxicity of testicular cancer. Dtsch Arztebl. 2005;102:A 3342–8 (Heft 48).

10.

Gerl A, Clemm C, Schmeller N, Hentrich M, Lamerz R, Wilmanns W. Late relapse of germ cell tumors after cisplatin-based chemotherapy. Ann Oncol. 1997;8(1):41–7. CrossRefPubMed

11.

Oldenburg J, Alfsen GC, Waehre H, Fossá SD. Late recurrences of germ cell malignancies: a population-based experience over three decades. Br J Cancer. 2006;94(6):820–7. PubMedCentralCrossRefPubMed

12.

Geldart TR, Gale J, McKendrick J, Kirby J, Mead G. Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure. BJU Int. 2006;98(2):353–8. CrossRefPubMed

13.

Ronnen EA, Kondagunta GV, Bacik J, Marion S, Bajorin DF, Sheinfeld J, Bosl GJ, Motzer RJ. Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy. J Clin Oncol. 2005;23(28):6999–7004. CrossRefPubMed

14.

15.

Arafat W, Albany C, Ulbright TM, Foster R, Einhorn LH. Very late relapse of germ cell tumor as a teratoma: a case report and review of the literature. J Surg Case Rep. 2014;2014(6):rju051. PubMedCentralCrossRefPubMed

16.

Pavic M, Meeus P, Treilleux I, Droz JP. Malignant teratoma 32 years after treatment of germ cell tumor confined to testis. Urology. 2006;67(4):846. CrossRefPubMed

17.

Plaza JA, Perez-Montiel D, Mayerson J, Morrison C, Suster S. Metastases to soft tissue: a review of 118 cases over a 30-year period. Cancer. 2008;112:193–203. doi: 10.1002/cncr.23151. CrossRefPubMed

18.

Bilici A, Ustaalioglu BB, Seker M, Kayahan S. Soft tissue metastasis from immature teratoma of the testis: second case report and review of the literature. Clin Orthop Relat Res. 2010;468(9):2541–4. PubMedCentralCrossRefPubMed

19.

Oosterhuis JW, Peeters SH, Smit VT, Stoop H, Looijenga LH, Elzevier HW, Osanto S. Patient with two secondary somatic-type malignancies in a late recurrence of a testicular non-seminoma: illustration of potential and flaw of the cancer stem cell therapy concept. Int J Dev Biol. 2013;57(2–4):153–7. CrossRefPubMed

20.

Zeh N, Wild PJ, Bode PK, Kristiansen G, Moch H, Sulser T, Hermanns T. Retroperitoneal teratoma with somatic malignant transformation: a papillary renal cell carcinoma in a testicular germ cell tumor metastasis following platinum-based chemotherapy. BMC Urol. 2013;13:9. PubMedCentralCrossRefPubMed

21.

Fung C, Fossa SD, Milano MT, Oldenburg J, Travis LB. Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study. J Clin Oncol. 2013;31(30):3807–14. PubMedCentralCrossRefPubMed

22.

Mesbahi O E, Terrier-Lacombe MJ, Rebischung C, Theodore C, Vanel D, Fizazi K. Chemotherapy in patients with teratoma with malignant transformation. Eur Urol. 2007;51(5):1306–11. CrossRefPubMed

23.

Vaughn DJ, Hwang W, Lal P, Rosen MA, Gallagher M, O’Dwyer PJ. Phase 2 trial of the cyclin-dependent kinase 4/6 inhibitor palbociclib in patients with retinoblastoma protein-expressing germ cell tumors. Cancer. 2015;121(9):1463–8. CrossRefPubMed

Titel: A 59-year-old patient with somatic type malignancy as a relapse of testicular tumor after 28 years
A patient with somatic type malignancy
Autoren:: MD Andreas Edwin Juarso
MD Malte Kiehl
MD Olaf Pfennig
MD Günther Wittenberg
MD Florian Weissinger
Publikationsdatum: 01.09.2015
DOI: https://doi.org/10.1007/s12254-015-0222-8
Verlag: Springer Vienna
Zeitschrift: memo - Magazine of European Medical Oncology An International Journal for Oncology and Haematology Professionals
Ausgabe 3/2015
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076

Springer Medizin Österreich

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

Abo für kostenpflichtige Inhalte

Weitere Artikel der Ausgabe 3/2015

Indolent lymphoma at ASH 2014: new kids on the block (iDrugs)

ASH 2014 highlights: new therapeutic concepts for T cell lymphomas

“Just because your doctor has a name for your condition doesn’t mean he knows what it is.” Bertrand Russell

Highlights of the American Society of Hematology Meeting 2014: Hemostaseology

Prognostic factors and their correlation with staging in patients with multiple myeloma: a single centre study in North India

Notes on breast cancer prevention and screening